This page shows the latest European Respiratory Society news and features for those working in and with pharma, biotech and healthcare.
The late-breaking data was presented at the European Respiratory Society (ERS) 2022 congress and demonstrated a consistent safety profile and efficacy for up to two years for children in this ... The safety results of the trial were generally consistent
Presented at the European Respiratory Society meeting in Barcelona, the announcement marks the first time artificial intelligence (AI) using convolutional neural networks has been used to analyse trial data involving the
The UK pharma group reported the results of two studies at the European Respiratory Society (ERS) in London, which showed the interleukin-5 (IL-5) inhibitor was able to reduce attacks
Positive results due to be presented at European Respiratory Society . Data due to be reported at a medical conference next week shows Roche's Esbriet can improve survival in idiopathic pulmonary ... deal. The new data - due to be presented to doctors
standards. The breach comes after a pulmonologist working in Germany complained about a scientific symposium organised by Boehringer at the European Respiratory Society (ERS) Congress, held in Munich last year. ... Boehringer currently markets the
The performance of GSK's respiratory portfolio dragged down group revenues as a whole last year, and GSK is now banking on a series of new products launches - including LAMA/LABA ... One set back for the triple therapies came last year, however, when a
More from news
Approximately 1 fully matching, plus 17 partially matching documents found.
increased incrementally, the curve of the European Respiratory Society congress (22, 094 vs 33, 784) saw its 2019 demographic increased by more than 50%. ... Another look at the 2020 European Respiratory Society statistics illustrates the high value
This study was the first to investigate an anti-IL-5 therapy in patients with nasal polyps and the data was presented for the first time at the European Respiratory Society ... GSK has an extraordinary heritage in respiratory research to try to benefit
Other patient and clinical interest groups put the figure even higher, with the European Respiratory Society placing the number at 300 million, with figures rising higher in nations with poor access ... COPD was a Cinderella disease when I started in
Respiratory biologics are booming thanks to scientists who refused to be derailed by early research setbacks. ... The company’s severe eosinophilic asthma biologic Nucala (mepoluzimab), an Interleukin-5 inhibitor, has been buoyed by a real-world
At the European Respiratory Society (ERS) congress 2015, we convened the world’s first three-university simultaneous hackathon with over 400 participants from Massachusetts Institute of Technology (MIT), Imperial College London
More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.
Wave combine scientific, medical and brand expertise to deliver clinically focused programmes that are trusted by HCPs, drive better patient...